Topics

9/10/19

The Jacobs School of Medicine and Biomedical Sciences continues to be at the forefront in combating the opioid overdose crisis.

8/13/19

A program developed by emergency medicine physicians at the Jacobs School of Medicine and Biomedical Sciences to expedite patient access to comprehensive and effective opioid use disorder treatment is expanding statewide.

7/22/19

The Jacobs School of Medicine and Biomedical Sciences and UB’s Clinical and Research Institute on Addictions (CRIA) played host to a prestigious Fulbright Enrichment Seminar on the opioid epidemic that brought 79 Fulbright Foreign Students from 51 countries to downtown Buffalo.

6/21/19

Medical student Esha Chebolu has been selected to participate in a yearlong residential program that trains the next generation of clinician-scientists and biomedical researchers on the National Institutes of Health (NIH) campus in Bethesda, Maryland.

6/11/19

Andrew H. Talal, MD — who pioneered the use of telemedicine to treat patients with hepatitis C virus (HCV) in opioid treatment programs — has shared the successes of this approach with the National Academy of Medicine (NAM).

5/30/19

Two institutions within the University at Buffalo have joined the National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic.

3/7/19

Jun-Xu Li, MD, PhD, associate professor of pharmacology and toxicology, is being recognized by the American Society for Pharmacology and Experimental Therapeutics (ASPET) with the inaugural JH Woods Early Career Award in Behavioral Pharmacology.

1/24/19

Researchers in the Department of Emergency Medicine are the first to clinically assess and validate a rule regarding the length of observation time necessary before opioid overdose patients can be safely discharged from an emergency department (ED).

12/11/18

Kenneth E. Leonard, PhD, professor of psychiatry and director of the UB Clinical and Research Institute on Addictions (CRIA), and Peter L. Elkin, MD, professor and chair of biomedical informatics, have been awarded a two-year, $386,013 grant from the National Institute on Alcohol Abuse and Alcoholism to assess what risks may occur for people with alcohol use disorder (AUD) who use prescription painkillers.

12/11/18

Jennifer A. Martin, a doctoral student in the Department of Pharmacology and Toxicology, has received a prestigious Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience Award from the National Institutes of Health (NIH).

12/3/18

An innovative, cost-effective program at more than a dozen hospitals in Western New York provides medication-assisted treatment to opioid use disorder patients in emergency departments (EDs) and rapidly transitions them into long-term treatment at a community clinic, all within about 48 hours.

11/20/18

Interprofessional collaboration is a key component in addressing the nation’s opioid epidemic, students from the Jacobs School of Medicine and Biomedical Sciences and other UB schools were told during the third annual forum on the topic.

5/24/18

UB’s Clinical and Translational Science Institute (CTSI) has awarded new grants that support promising translational research projects in Western New York.

4/18/18

Research led by senior author David Dietz, PhD, has revealed that in certain types of brain cells, drug-induced plasticity can work to reduce motivation for heroin.

3/22/18

A total of 37 original research projects from aspiring physician-scientists were on display at the 2018 Medical Student Research Forum.

1/10/18

The Western New York community has enlisted experts from the Jacobs School of Medicine and Biomedical Sciences to help combat the national opioid epidemic, which has reached crisis proportions.

12/11/17

The value of interprofessional collaboration in dealing with the opioid crisis was highlighted as students and staff from the Jacobs School of Medicine and Biomedical Sciences joined other UB schools of study during a forum on opioid dependence.

10/12/17

The Research Institute on Addictions (RIA) and faculty from the Jacobs School of Medicine and Biomedical Sciences (JSMBS) are leading an effort to combat the opioid crisis throughout the state.

5/3/17

UB researchers are developing innovative ways to better diagnose and treat hepatitis C virus (HCV) in people with substance abuse disorders.

1/31/17

Students from the Jacobs School of Medicine and Biomedical Sciences joined hundreds of their UB peers in the health professions, social work, law and management for an interprofessional forum on opioid dependence.